BMS-309403 is a synthetic, cell-permeable, and orally active chemical compound that acts as a potent and selective inhibitor of fatty acid binding protein 4 (FABP4), also known as aP2. It is being researched for its potential in treating conditions like type 2 diabetes and atherosclerosis due to its ability to reduce inflammation and improve insulin sensitivity.